|
|
福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.68 (2022) >
このアイテムの引用には次の識別子を使用してください:
http://ir.fmu.ac.jp/dspace/handle/123456789/1642
|
| タイトル: | Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer |
| 著者: | Sugimoto, Mitsuru
Takagi, Tadayuki
Suzuki, Rei
Konno, Naoki
Asama, Hiroyuki
Sato, Yuki
Irie, Hiroki
Okubo, Yoshinori
Nakamura, Jun
Takasumi, Mika
Hashimoto, Minami
Kato, Tsunetaka
Kobashi, Ryoichiro
Hikichi, Takuto
Ohira, Hiromasa |
| 学内所属: | 消化器内科学講座
内視鏡診療部 |
| 誌名/書名: | Fukushima Journal of Medical Science |
| 巻: | 68 |
| 号: | 1 |
| 開始ページ: | 1 |
| 終了ページ: | 10 |
| 発行日: | 2022年 |
| 抄録: | Pancreatic cancer (PC) is a lethal disease where most tumors are too advanced at diagnosis for resection, leaving chemotherapy as the mainstay of treatment. Although the prognosis of unresectable PC is poor, it has been dramatically improved by new chemotherapy treatments, such as the combination of 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin (FOLFIRINOX) or gemcitabine plus nab-paclitaxel. However, as oxaliplatin and paclitaxel are common neurotoxic drugs, chemotherapy-induced peripheral neuropathy (CIPN) is a common and severe adverse effect of both treatments. As there are no agents recommended in the ASCO guidelines, we review the methods used to treat CIPN caused by PC treatment. The efficacy of duloxetine was observed in a large randomized controlled trial (RCT). In addition, pregabalin was more effective than duloxetine for CIPN in two RCTs. Although duloxetine and pregabalin can be effective for CIPN, they have several side effects. Therefore, the choice between the two drugs should be determined according to effect and tolerability. Mirogabalin is also used in patients with PC and there is hope it will yield positive outcomes when treating CIPN in the future. |
| 出版者: | The Fukushima Society of Medical Science |
| 出版者（異表記）: | 福島医学会 |
| 本文の言語: | eng |
| このページのURI: | http://ir.fmu.ac.jp/dspace/handle/123456789/1642 |
| 本文URL: | http://ir.fmu.ac.jp/dspace/bitstream/123456789/1642/1/FksmJMedSci_68_p1.pdf |
| ISSN: | 0016-2590
2185-4610 |
| DOI: | 10.5387/fms.2021-32 |
| PubMed番号: | 35197393 |
| 関連ページ: | https://doi.org/10.5387/fms.2021-32 |
| 権利情報: | © 2022 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license. |
| 権利情報: | https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| 出現コレクション: | Vol.68 (2022)
|
このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。
|
